CD4 and neoplasm: As an initial test of this hypothesis, we challenged B6 mice with the various live OVA expressing tumor lines and compared their ability to expand OVA specific CD4 T cells (OT-II cells) or CD8 T cells (OT-1 T cells) in vivo.